Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises in conjunction with sale of Euroflorist
Mandate

Vinge advises in conjunction with sale of Euroflorist

December 20, 2021 Corporate Tax M&A EU, Competition and Regulatory

Vinge has advised the stakeholders of Euroflorist in conjunction with the sale of its subsidiary Euroflorist Holding, including all operative subsidiaries, to a Swedish consortium headed by Magnus Silfverberg, previously CEO of Betsson and Bisnode, and Johan Tjärnberg, CEO of Trustly and previously the founder and CEO of Bambora, together with a group of investors. Euroflorist is a leading international platform for the sale of flowers online.

Vinge’s team primarily consisted of Johan Winnerblad, Vilhelm Rondahl, Ellinor Wargenbrant, Linnea Petersson, Mattias Schömer, Sebastian Örndahl, Arvid Axelryd and Viktoria Owetz Leyva.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026